Mirum Pharmaceuticals, Inc.

Direct answer

Mirum Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker MIRM.

Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address...

Can you invest in Mirum Pharmaceuticals, Inc.?

Yes. Mirum Pharmaceuticals, Inc. trades publicly on NASDAQ as MIRM.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Mirum Pharmaceuticals, Inc.

Detailed equity research is provided by MarketSnap.